Brown, Lisle/Cummings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.21M | Sell |
28,045
-174
| -0.6% | -$32.3K | 1.39% | 16 |
|
|
2025
Q1 | $5.91M | Buy |
28,219
+181
| +0.6% | +$37.9K | 1.71% | 10 |
|
|
2024
Q4 | $4.98M | Sell |
28,038
-53
| -0.2% | -$9.42K | 1.49% | 12 |
|
|
2024
Q3 | $5.55M | Buy |
28,091
+1,450
| +5% | +$286K | 1.69% | 11 |
|
|
2024
Q2 | $4.57M | Buy |
26,641
+1,124
| +4% | +$193K | 1.49% | 13 |
|
|
2024
Q1 | $4.65M | Hold |
25,517
| – | – | 1.58% | 12 |
|
|
2023
Q4 | $3.95M | Buy |
25,517
+4,025
| +19% | +$624K | 1.47% | 12 |
|
|
2023
Q3 | $3.2M | Buy |
21,492
+425
| +2% | +$63.4K | 1.45% | 17 |
|
|
2023
Q2 | $2.84M | Buy |
21,067
+1,125
| +6% | +$152K | 1.27% | 20 |
|
|
2023
Q1 | $3.18M | Sell |
19,942
-26
| -0.1% | -$4.14K | 1.61% | 12 |
|
|
2022
Q4 | $3.23M | Sell |
19,968
-953
| -5% | -$154K | 1.73% | 10 |
|
|
2022
Q3 | $2.81M | Hold |
20,921
| – | – | 1.64% | 13 |
|
|
2022
Q2 | $3.2M | Sell |
20,921
-7
| -0% | -$1.07K | 1.77% | 13 |
|
|
2022
Q1 | $3.39M | Buy |
20,928
+65
| +0.3% | +$10.5K | 1.63% | 13 |
|
|
2021
Q4 | $2.82M | Buy |
+20,863
| New | +$2.82M | 1.41% | 15 |
|